CDCP1 activators would be a specialized class of compounds that modulate the activity of the CUB domain-containing protein 1 (CDCP1), which is a transmembrane protein implicated in various cellular processes including cell adhesion, migration, and proliferation. CDCP1 has been shown to play a role in signal transduction by interacting with other proteins such as Src family kinases, and it is phosphorylated upon activation, which is a critical step in the initiation of downstream signaling cascades.
Direct activators of CDCP1 are likely to engage with the protein in a manner that promotes its phosphorylation status or preserves its phosphorylated form. These activators could bind to the extracellular domain of CDCP1, inducing a conformational change that enables the intracellular domain to become more accessible to kinases that mediate its phosphorylation. Alternatively, they might interact with the intracellular domain directly, enhancing its interaction with kinases or stabilizing the active form of the protein. Indirect CDCP1 activators could increase the expression levels of CDCP1 by enhancing the transcription of the CDCP1 gene, thereby augmenting the amount of protein available for activation. They might also modulate other signaling pathways that converge on CDCP1, leading to its activation. Additionally, these activators could inhibit phosphatases that dephosphorylate CDCP1, resulting in increased levels of the phosphorylated, and thus active, form of the protein..
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC) which is known to phosphorylate and activate CDCP1. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol activates the PI3K/AKT pathway. The activation of AKT can lead to the phosphorylation of CDCP1, leading to its activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the PI3K/AKT pathway, leading to the phosphorylation and activation of CDCP1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P leads to activation of the S1P receptor and downstream signaling, including the PI3K/AKT pathway, which can phosphorylate and activate CDCP1. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates the LPA receptor leading to downstream signaling, including the PI3K/AKT pathway which can phosphorylate and activate CDCP1. | ||||||
Ob (hBA-147) | sc-4912 | 1000 µg | $258.00 | 1 | ||
Leptin activates the JAK2/STAT3 pathway, which can lead to the activation of CDCP1. | ||||||
Oxytocin acetate salt | 50-56-6 | sc-279938 sc-279938A sc-279938B sc-279938C sc-279938D sc-279938E | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $60.00 $180.00 $337.00 $663.00 $969.00 $1836.00 | 4 | |
Oxytocin can activate the MAPK pathway, which can induce the activation of CDCP1. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II can activate the MAPK pathway, which can induce the activation of CDCP1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase leading to increased cAMP levels, which can activate the cAMP/PKA pathway, leading to phosphorylation and activation of CDCP1. | ||||||